Patients On pharmacy, digital, new care prevention, with Opella UK In a new episode, Nick Linton, head of Opella UK, discusses why community pharmacy should be seen as a core part of the prevention agenda.
News RevMed hails first-line data with pancreatic cancer drug Revolution Medicine's fast-growing pan-RAS inhibitor Rasonque has generated exciting results as a first-line treatment for pancreatic cancer.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.